NEUROCRINE BIOSCIENCES INC (NBIX)

SEC filing

NEUROCRINE BIOSCIENCES INC

NBIX · CIK 914475

4 · Sep 15, 2026 · Chief Financial Officer ABERNETHY MATT sold 2,311 shares at $157.20/share ($363.3K); was granted 5,020 shares; reported 2,709 shares

Chief Financial Officer ABERNETHY MATT sold 2,311 shares at $157.20/share ($363.3K); was granted 5,020 shares; reported 2,709 shares

Filed: Sep 15, 2026
Period: Sep 11, 2026
Accession: 0001724097-26-000010
Filer: NEUROCRINE BIOSCIENCES INC

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1789506139.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1789506139.xml
Open SEC.gov